Login to Your Account



Other News To Note


Tuesday, January 18, 2011
Orexo AB, of Uppsala, Sweden, and Invida Group Private Ltd., of Singapore, signed an exclusive licensing and distribution agreement for Abstral, a cancer pain therapy.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription